BioInfra Co., Ltd. (KOSDAQ:199730)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,510.00
-21.00 (-1.37%)
At close: Sep 3, 2026

BioInfra Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-8,287-9,131-3,9762,0026,2376,234
Depreciation & Amortization
3,5423,4353,3162,3881,9801,180
Loss (Gain) From Sale of Assets
27.317.3--0.05-903.7-33.04
Loss (Gain) From Sale of Investments
1,7441,744716.38135.17--
Loss (Gain) on Equity Investments
-83.72-42.03-1.86-138.5-24.79209.88
Stock-Based Compensation
38.28--510.5816.8306.3
Provision & Write-off of Bad Debts
-14.8337.23107.182.454.85-180.76
Other Operating Activities
1,1981,085-1,905-1,109610.29817.59
Change in Accounts Receivable
-1,118240.66866.07158.68594.96-2,812
Change in Accounts Payable
87.2640.3-29.81-737.29739.411,200
Change in Income Taxes
6.6728.35-77.38-20.73--
Change in Other Net Operating Assets
1,511443.832,714-2,591-1,630-359.31
Operating Cash Flow
-1,350-1,5011,729679.38,4256,563
Operating Cash Flow Growth
--154.55%-91.94%28.36%57.35%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,154-1,322-2,800-3,074-10,531-14,122
Sale of Property, Plant & Equipment
---0.52-323.72
Sale (Purchase) of Intangibles
-138.86-141.86-70.61-623.33-346.39-303.32
Investment in Securities
2,505991.84-2,700-6,999217.81-802.8
Other Investing Activities
---010,538-
Investing Cash Flow
1,212-472.43-5,571-10,696-121.44-14,904

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-2,500---3,567
Long-Term Debt Issued
--4,200-4,00011,600
Total Debt Issued
2,0002,5004,200-4,00015,167
Short-Term Debt Repaid
-----2,800-4,527
Long-Term Debt Repaid
--468.75-4,590-203.15-7,916-3,692
Total Debt Repaid
-482.33-468.75-4,590-203.15-10,716-8,218
Net Debt Issued (Repaid)
1,5182,031-390.36-203.15-6,7166,948
Issuance of Common Stock
--448.913,552--
Dividends Paid
-1,459-1,946-2,878---
Other Financing Activities
-0---0-6.6-0
Financing Cash Flow
58.3685.51-2,82013,349-6,7236,948

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Miscellaneous Cash Flow Adjustments
0--00-00
Net Cash Flow
-79.29-1,888-6,6613,3321,580-1,393

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2,504-2,824-1,071-2,395-2,107-7,559
Free Cash Flow Growth
------
Free Cash Flow Margin
-9.77%-12.20%-4.49%-7.95%-5.95%-24.74%
Free Cash Flow Per Share
-514.91-580.50-220.92-509.75-510.36-1830.82
Levered Free Cash Flow
675.31-690.14846.51-4,172-4,977-9,793
Unlevered Free Cash Flow
927.78-460.651,082-3,905-4,746-9,654

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
353.37341.98362.23409.36341.53171.76
Cash Income Tax Paid
--18.11342.89144.7466.09
Change in Working Capital
486.91,3533,472-3,190-296.12-1,971